Adaptive platform trials are accelerating infectious disease research by allowing multiple treatments to be tested simultaneously and new candidates to be added as data emerges, according to a World Report in The Lancet.
Adaptive Platform Trials Reshape Infectious Disease Research
Adaptive platform trials are accelerating infectious disease research by allowing multiple treatments to be tested simultaneously and new candidates to be added as data emerges, according to a World Report in The Lancet.
![[World Report] Platform trials: the study design transforming infectious diseases](https://nbg1.your-objectstorage.com/ckln/image-assets/071aa2d8297cd51b2c6d1a6fff646592ddb0a4300d73bb64500349ed6b01fa54.jpg)
Infectious mononucleosis · Wikimedia — licence per file · rights
Monitoring item. The full text is not distributed. Extract and source below.